InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.400
+0.040 (2.94%)
Sep 29, 2026, 2:42 PM EDT - Market open
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 6 employees as of June 30, 2026. The number of employees decreased by 7 or -53.85% compared to the previous year.
Employees
6
Change (1Y)
-7
Growth (1Y)
-53.85%
Revenue / Employee
n/a
Profits / Employee
-$2,093,475
Market Cap
9.30M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 6 | -7 | -53.85% | 6 | 0 |
| Jun 30, 2025 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2024 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2023 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2022 | 13 | 1 | 8.33% | 13 | 0 |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Biofrontera | 94 |
| Aytu BioPharma | 83 |
| IM Cannabis | 44 |
| cbdMD | 42 |
| Sonoma Pharmaceuticals | 10 |
| Gelteq | 8 |
| PRF Technologies | 7 |
| Caring Brands | 3 |
INM News
- 10 days ago - InMed receives Nasdaq notification from listing qualifications department - TheFly
- 10 days ago - InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Shareholders' Equity Compliance - Newsfile Corp
- 19 days ago - InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate Update - Newsfile Corp
- 20 days ago - InMed Pharmaceuticals Annual report: Q4 2026 - Filings
- 20 days ago - InMed Pharmaceuticals Earnings release: Q4 2026 - Filings
- 2 months ago - Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline - PRNewsWire
- 2 months ago - InMed Pharmaceuticals amends merger pact with Mentari Therapeutics - TheFly
- 2 months ago - InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4 - Newsfile Corp